article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

UK Spring Budget allocates funds to life sciences manufacturing

Pharmaceutical Technology

The UK Government announced plans to bolster the UK life science manufacturing industry through increased investment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

TANAKA Contributes to Ambix Life Science Fund

Pharma Mirror

and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., The post TANAKA Contributes to Ambix Life Science Fund appeared first on Pharma Mirror Magazine. Background to and Objectives.

article thumbnail

New facility boosts UK’s cell and gene therapy manufacturing capacity

Pharmaceutical Technology

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. This is important due to the UK’s currently limited short-scale manufacturing capacity.

article thumbnail

UK must not overlook manufacturing in life sciences drive

pharmaphorum

UK must not overlook manufacturing in life sciences drive Phil.Taylor Tue, 13/06/2023 - 06:47 Bookmark this

article thumbnail

How the Life Sciences Innovative Manufacturing Fund can boost funding for pharma

pharmaphorum

Discover how the Life Sciences Innovative Manufacturing Fund can help boost funding for pharmaceutical companies. Learn how this fund can support innovation and growth in the life sciences sector.

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country.